Clinical Trial Update: Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases [Phase 1]

View source ↗

Summary

A Phase 1 trial of vemurafenib in combination with whole-brain radiation therapy or radiosurgery for patients with BRAF-mutant melanoma and brain metastases was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Zelboraf (vemurafenib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Recurrent Melanoma, Stage IV Melanoma | Phase 1 | Status: WITHDRAWN